U.S. markets open in 6 hours 38 minutes
  • S&P Futures

    3,440.25
    -9.00 (-0.26%)
     
  • Dow Futures

    28,215.00
    -53.00 (-0.19%)
     
  • Nasdaq Futures

    11,626.00
    -23.75 (-0.20%)
     
  • Russell 2000 Futures

    1,627.90
    -2.70 (-0.17%)
     
  • Crude Oil

    40.36
    -0.28 (-0.69%)
     
  • Gold

    1,907.00
    +2.40 (+0.13%)
     
  • Silver

    24.72
    +0.01 (+0.02%)
     
  • EUR/USD

    1.1804
    -0.0022 (-0.19%)
     
  • 10-Yr Bond

    0.8480
    0.0000 (0.00%)
     
  • Vix

    28.11
    -0.54 (-1.88%)
     
  • GBP/USD

    1.3059
    -0.0021 (-0.16%)
     
  • USD/JPY

    104.7210
    -0.1190 (-0.11%)
     
  • BTC-USD

    12,907.50
    -59.24 (-0.46%)
     
  • CMC Crypto 200

    260.73
    +4.63 (+1.81%)
     
  • FTSE 100

    5,785.65
    +9.15 (+0.16%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Global Drugs of Abuse Testing Industry

ReportLinker
·29 mins read

Global Drugs of Abuse Testing Market to Reach $6. 2 Billion by 2027. Amid the COVID-19 crisis, the global market for Drugs of Abuse Testing estimated at US$4. 8 Billion in the year 2020, is projected to reach a revised size of US$6.

New York, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Drugs of Abuse Testing Industry" - https://www.reportlinker.com/p05960901/?utm_source=GNW
2 Billion by 2027, growing at aCAGR of 3.8% over the period 2020-2027. Equipment, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 3.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 6.9% CAGR

The Drugs of Abuse Testing market in the U.S. is estimated at US$1.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 6.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.2% and 2.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.We bring years of research experience to this 7th edition of our report. The 380-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories

  • Danaher Corporation

  • Dragerwerk AG & Co. KGaA

  • F. Hoffmann-La Roche AG

  • Laboratory Corporation of America Holdings (LabCorp)

  • Siemens Healthineers

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p05960901/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Drugs of Abuse Testing Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Drugs of Abuse Testing Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Drugs of Abuse Testing Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Drugs of Abuse Testing Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Equipment (Product Type) World Market by
Region/Country in US$ Million: 2020 to 2027

Table 5: Equipment (Product Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 6: Equipment (Product Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Consumables (Product Type) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027

Table 8: Consumables (Product Type) Historic Market Perspective
by Region/Country in US$ Million: 2012 to 2019

Table 9: Consumables (Product Type) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Saliva (Sample Type) Geographic Market Spread
Worldwide in US$ Million: 2020 to 2027

Table 11: Saliva (Sample Type) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2012 to 2019

Table 12: Saliva (Sample Type) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 13: Breath (Sample Type) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2020 to 2027

Table 14: Breath (Sample Type) Market Historic Review by
Region/Country in US$ Million: 2012 to 2019

Table 15: Breath (Sample Type) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027

Table 16: Urine (Sample Type) World Market by Region/Country in
US$ Million: 2020 to 2027

Table 17: Urine (Sample Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 18: Urine (Sample Type) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 19: Blood (Sample Type) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2020 to 2027

Table 20: Blood (Sample Type) Market Worldwide Historic Review
by Region/Country in US$ Million: 2012 to 2019

Table 21: Blood (Sample Type) Market Percentage Share
Distribution by Region/Country: 2012 VS 2020 VS 2027

Table 22: Hair & Sweat (Sample Type) Market Opportunity
Analysis Worldwide in US$ Million by Region/Country: 2020 to
2027

Table 23: Hair & Sweat (Sample Type) Global Historic Demand in
US$ Million by Region/Country: 2012 to 2019

Table 24: Hair & Sweat (Sample Type) Market Share Distribution
in Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 25: Hospitals (End-Use) Worldwide Sales in US$ Million by
Region/Country: 2020-2027

Table 26: Hospitals (End-Use) Historic Demand Patterns in US$
Million by Region/Country: 2012-2019

Table 27: Hospitals (End-Use) Market Share Shift across Key
Geographies: 2012 VS 2020 VS 2027

Table 28: Diagnostic Laboratories (End-Use) Global Market
Estimates & Forecasts in US$ Million by Region/Country:
2020-2027

Table 29: Diagnostic Laboratories (End-Use) Retrospective
Demand Analysis in US$ Million by Region/Country: 2012-2019

Table 30: Diagnostic Laboratories (End-Use) Market Share
Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 31: On-the-spot Testing (End-Use) Demand Potential
Worldwide in US$ Million by Region/Country: 2020-2027

Table 32: On-the-spot Testing (End-Use) Historic Sales Analysis
in US$ Million by Region/Country: 2012-2019

Table 33: On-the-spot Testing (End-Use) Share Breakdown Review
by Region/Country: 2012 VS 2020 VS 2027

Table 34: Forensic Laboratories (End-Use) Worldwide Latent
Demand Forecasts in US$ Million by Region/Country: 2020-2027

Table 35: Forensic Laboratories (End-Use) Global Historic
Analysis in US$ Million by Region/Country: 2012-2019

Table 36: Forensic Laboratories (End-Use) Distribution of
Global Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Drugs of Abuse Testing Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 37: United States Drugs of Abuse Testing Market Estimates
and Projections in US$ Million by Product Type: 2020 to 2027

Table 38: Drugs of Abuse Testing Market in the United States by
Product Type: A Historic Review in US$ Million for 2012-2019

Table 39: United States Drugs of Abuse Testing Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 40: United States Drugs of Abuse Testing Market Estimates
and Projections in US$ Million by Sample Type: 2020 to 2027

Table 41: Drugs of Abuse Testing Market in the United States by
Sample Type: A Historic Review in US$ Million for 2012-2019

Table 42: United States Drugs of Abuse Testing Market Share
Breakdown by Sample Type: 2012 VS 2020 VS 2027

Table 43: United States Drugs of Abuse Testing Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 44: Drugs of Abuse Testing Historic Demand Patterns in
the United States by End-Use in US$ Million for 2012-2019

Table 45: Drugs of Abuse Testing Market Share Breakdown in the
United States by End-Use: 2012 VS 2020 VS 2027

CANADA
Table 46: Canadian Drugs of Abuse Testing Market Estimates and
Forecasts in US$ Million by Product Type: 2020 to 2027

Table 47: Canadian Drugs of Abuse Testing Historic Market
Review by Product Type in US$ Million: 2012-2019

Table 48: Drugs of Abuse Testing Market in Canada: Percentage
Share Breakdown of Sales by Product Type for 2012, 2020, and
2027

Table 49: Canadian Drugs of Abuse Testing Market Estimates and
Forecasts in US$ Million by Sample Type: 2020 to 2027

Table 50: Canadian Drugs of Abuse Testing Historic Market
Review by Sample Type in US$ Million: 2012-2019

Table 51: Drugs of Abuse Testing Market in Canada: Percentage
Share Breakdown of Sales by Sample Type for 2012, 2020, and
2027

Table 52: Canadian Drugs of Abuse Testing Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 53: Drugs of Abuse Testing Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 54: Canadian Drugs of Abuse Testing Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

JAPAN
Table 55: Japanese Market for Drugs of Abuse Testing: Annual
Sales Estimates and Projections in US$ Million by Product Type
for the Period 2020-2027

Table 56: Drugs of Abuse Testing Market in Japan: Historic
Sales Analysis in US$ Million by Product Type for the Period
2012-2019

Table 57: Japanese Drugs of Abuse Testing Market Share Analysis
by Product Type: 2012 VS 2020 VS 2027

Table 58: Japanese Market for Drugs of Abuse Testing: Annual
Sales Estimates and Projections in US$ Million by Sample Type
for the Period 2020-2027

Table 59: Drugs of Abuse Testing Market in Japan: Historic
Sales Analysis in US$ Million by Sample Type for the Period
2012-2019

Table 60: Japanese Drugs of Abuse Testing Market Share Analysis
by Sample Type: 2012 VS 2020 VS 2027

Table 61: Japanese Demand Estimates and Forecasts for Drugs of
Abuse Testing in US$ Million by End-Use: 2020 to 2027

Table 62: Japanese Drugs of Abuse Testing Market in US$ Million
by End-Use: 2012-2019

Table 63: Drugs of Abuse Testing Market Share Shift in Japan by
End-Use: 2012 VS 2020 VS 2027

CHINA
Table 64: Chinese Drugs of Abuse Testing Market Growth
Prospects in US$ Million by Product Type for the Period
2020-2027

Table 65: Drugs of Abuse Testing Historic Market Analysis in
China in US$ Million by Product Type: 2012-2019

Table 66: Chinese Drugs of Abuse Testing Market by Product
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 67: Chinese Drugs of Abuse Testing Market Growth
Prospects in US$ Million by Sample Type for the Period
2020-2027

Table 68: Drugs of Abuse Testing Historic Market Analysis in
China in US$ Million by Sample Type: 2012-2019

Table 69: Chinese Drugs of Abuse Testing Market by Sample Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 70: Chinese Demand for Drugs of Abuse Testing in US$
Million by End-Use: 2020 to 2027

Table 71: Drugs of Abuse Testing Market Review in China in US$
Million by End-Use: 2012-2019

Table 72: Chinese Drugs of Abuse Testing Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Drugs of Abuse Testing Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 73: European Drugs of Abuse Testing Market Demand
Scenario in US$ Million by Region/Country: 2020-2027

Table 74: Drugs of Abuse Testing Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019

Table 75: European Drugs of Abuse Testing Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027

Table 76: European Drugs of Abuse Testing Market Estimates and
Forecasts in US$ Million by Product Type: 2020-2027

Table 77: Drugs of Abuse Testing Market in Europe in US$
Million by Product Type: A Historic Review for the Period
2012-2019

Table 78: European Drugs of Abuse Testing Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 79: European Drugs of Abuse Testing Market Estimates and
Forecasts in US$ Million by Sample Type: 2020-2027

Table 80: Drugs of Abuse Testing Market in Europe in US$
Million by Sample Type: A Historic Review for the Period
2012-2019

Table 81: European Drugs of Abuse Testing Market Share
Breakdown by Sample Type: 2012 VS 2020 VS 2027

Table 82: European Drugs of Abuse Testing Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027

Table 83: Drugs of Abuse Testing Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 84: European Drugs of Abuse Testing Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

FRANCE
Table 85: Drugs of Abuse Testing Market in France by Product
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 86: French Drugs of Abuse Testing Historic Market
Scenario in US$ Million by Product Type: 2012-2019

Table 87: French Drugs of Abuse Testing Market Share Analysis
by Product Type: 2012 VS 2020 VS 2027

Table 88: Drugs of Abuse Testing Market in France by Sample
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 89: French Drugs of Abuse Testing Historic Market
Scenario in US$ Million by Sample Type: 2012-2019

Table 90: French Drugs of Abuse Testing Market Share Analysis
by Sample Type: 2012 VS 2020 VS 2027

Table 91: Drugs of Abuse Testing Quantitative Demand Analysis
in France in US$ Million by End-Use: 2020-2027

Table 92: French Drugs of Abuse Testing Historic Market Review
in US$ Million by End-Use: 2012-2019

Table 93: French Drugs of Abuse Testing Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027

GERMANY
Table 94: Drugs of Abuse Testing Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Product
Type for the Period 2020-2027

Table 95: German Drugs of Abuse Testing Historic Market
Analysis in US$ Million by Product Type: 2012-2019

Table 96: German Drugs of Abuse Testing Market Share Breakdown
by Product Type: 2012 VS 2020 VS 2027

Table 97: Drugs of Abuse Testing Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Sample Type
for the Period 2020-2027

Table 98: German Drugs of Abuse Testing Historic Market
Analysis in US$ Million by Sample Type: 2012-2019

Table 99: German Drugs of Abuse Testing Market Share Breakdown
by Sample Type: 2012 VS 2020 VS 2027

Table 100: Drugs of Abuse Testing Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 101: German Drugs of Abuse Testing Market in Retrospect
in US$ Million by End-Use: 2012-2019

Table 102: Drugs of Abuse Testing Market Share Distribution in
Germany by End-Use: 2012 VS 2020 VS 2027

ITALY
Table 103: Italian Drugs of Abuse Testing Market Growth
Prospects in US$ Million by Product Type for the Period
2020-2027

Table 104: Drugs of Abuse Testing Historic Market Analysis in
Italy in US$ Million by Product Type: 2012-2019

Table 105: Italian Drugs of Abuse Testing Market by Product
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 106: Italian Drugs of Abuse Testing Market Growth
Prospects in US$ Million by Sample Type for the Period
2020-2027

Table 107: Drugs of Abuse Testing Historic Market Analysis in
Italy in US$ Million by Sample Type: 2012-2019

Table 108: Italian Drugs of Abuse Testing Market by Sample
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 109: Italian Demand for Drugs of Abuse Testing in US$
Million by End-Use: 2020 to 2027

Table 110: Drugs of Abuse Testing Market Review in Italy in US$
Million by End-Use: 2012-2019

Table 111: Italian Drugs of Abuse Testing Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 112: United Kingdom Market for Drugs of Abuse Testing:
Annual Sales Estimates and Projections in US$ Million by
Product Type for the Period 2020-2027

Table 113: Drugs of Abuse Testing Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Product Type for the
Period 2012-2019

Table 114: United Kingdom Drugs of Abuse Testing Market Share
Analysis by Product Type: 2012 VS 2020 VS 2027

Table 115: United Kingdom Market for Drugs of Abuse Testing:
Annual Sales Estimates and Projections in US$ Million by Sample
Type for the Period 2020-2027

Table 116: Drugs of Abuse Testing Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Sample Type for the
Period 2012-2019

Table 117: United Kingdom Drugs of Abuse Testing Market Share
Analysis by Sample Type: 2012 VS 2020 VS 2027

Table 118: United Kingdom Demand Estimates and Forecasts for
Drugs of Abuse Testing in US$ Million by End-Use: 2020 to 2027

Table 119: United Kingdom Drugs of Abuse Testing Market in US$
Million by End-Use: 2012-2019

Table 120: Drugs of Abuse Testing Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027

SPAIN
Table 121: Spanish Drugs of Abuse Testing Market Estimates and
Forecasts in US$ Million by Product Type: 2020 to 2027

Table 122: Spanish Drugs of Abuse Testing Historic Market
Review by Product Type in US$ Million: 2012-2019

Table 123: Drugs of Abuse Testing Market in Spain: Percentage
Share Breakdown of Sales by Product Type for 2012, 2020, and
2027

Table 124: Spanish Drugs of Abuse Testing Market Estimates and
Forecasts in US$ Million by Sample Type: 2020 to 2027

Table 125: Spanish Drugs of Abuse Testing Historic Market
Review by Sample Type in US$ Million: 2012-2019

Table 126: Drugs of Abuse Testing Market in Spain: Percentage
Share Breakdown of Sales by Sample Type for 2012, 2020, and
2027

Table 127: Spanish Drugs of Abuse Testing Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 128: Drugs of Abuse Testing Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 129: Spanish Drugs of Abuse Testing Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

RUSSIA
Table 130: Russian Drugs of Abuse Testing Market Estimates and
Projections in US$ Million by Product Type: 2020 to 2027

Table 131: Drugs of Abuse Testing Market in Russia by Product
Type: A Historic Review in US$ Million for 2012-2019

Table 132: Russian Drugs of Abuse Testing Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 133: Russian Drugs of Abuse Testing Market Estimates and
Projections in US$ Million by Sample Type: 2020 to 2027

Table 134: Drugs of Abuse Testing Market in Russia by Sample
Type: A Historic Review in US$ Million for 2012-2019

Table 135: Russian Drugs of Abuse Testing Market Share
Breakdown by Sample Type: 2012 VS 2020 VS 2027

Table 136: Russian Drugs of Abuse Testing Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 137: Drugs of Abuse Testing Historic Demand Patterns in
Russia by End-Use in US$ Million for 2012-2019

Table 138: Drugs of Abuse Testing Market Share Breakdown in
Russia by End-Use: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 139: Rest of Europe Drugs of Abuse Testing Market
Estimates and Forecasts in US$ Million by Product Type:
2020-2027

Table 140: Drugs of Abuse Testing Market in Rest of Europe in
US$ Million by Product Type: A Historic Review for the Period
2012-2019

Table 141: Rest of Europe Drugs of Abuse Testing Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 142: Rest of Europe Drugs of Abuse Testing Market
Estimates and Forecasts in US$ Million by Sample Type:
2020-2027

Table 143: Drugs of Abuse Testing Market in Rest of Europe in
US$ Million by Sample Type: A Historic Review for the Period
2012-2019

Table 144: Rest of Europe Drugs of Abuse Testing Market Share
Breakdown by Sample Type: 2012 VS 2020 VS 2027

Table 145: Rest of Europe Drugs of Abuse Testing Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 146: Drugs of Abuse Testing Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 147: Rest of Europe Drugs of Abuse Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 148: Asia-Pacific Drugs of Abuse Testing Market Estimates
and Forecasts in US$ Million by Region/Country: 2020-2027

Table 149: Drugs of Abuse Testing Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2012-2019

Table 150: Asia-Pacific Drugs of Abuse Testing Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 151: Drugs of Abuse Testing Market in Asia-Pacific by
Product Type: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 152: Asia-Pacific Drugs of Abuse Testing Historic Market
Scenario in US$ Million by Product Type: 2012-2019

Table 153: Asia-Pacific Drugs of Abuse Testing Market Share
Analysis by Product Type: 2012 VS 2020 VS 2027

Table 154: Drugs of Abuse Testing Market in Asia-Pacific by
Sample Type: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 155: Asia-Pacific Drugs of Abuse Testing Historic Market
Scenario in US$ Million by Sample Type: 2012-2019

Table 156: Asia-Pacific Drugs of Abuse Testing Market Share
Analysis by Sample Type: 2012 VS 2020 VS 2027

Table 157: Drugs of Abuse Testing Quantitative Demand Analysis
in Asia-Pacific in US$ Million by End-Use: 2020-2027

Table 158: Asia-Pacific Drugs of Abuse Testing Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 159: Asia-Pacific Drugs of Abuse Testing Market Share
Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020, and
2027

AUSTRALIA
Table 160: Drugs of Abuse Testing Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Product
Type for the Period 2020-2027

Table 161: Australian Drugs of Abuse Testing Historic Market
Analysis in US$ Million by Product Type: 2012-2019

Table 162: Australian Drugs of Abuse Testing Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 163: Drugs of Abuse Testing Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Sample Type
for the Period 2020-2027

Table 164: Australian Drugs of Abuse Testing Historic Market
Analysis in US$ Million by Sample Type: 2012-2019

Table 165: Australian Drugs of Abuse Testing Market Share
Breakdown by Sample Type: 2012 VS 2020 VS 2027

Table 166: Drugs of Abuse Testing Market in Australia: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 167: Australian Drugs of Abuse Testing Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 168: Drugs of Abuse Testing Market Share Distribution in
Australia by End-Use: 2012 VS 2020 VS 2027

INDIA
Table 169: Indian Drugs of Abuse Testing Market Estimates and
Forecasts in US$ Million by Product Type: 2020 to 2027

Table 170: Indian Drugs of Abuse Testing Historic Market Review
by Product Type in US$ Million: 2012-2019

Table 171: Drugs of Abuse Testing Market in India: Percentage
Share Breakdown of Sales by Product Type for 2012, 2020, and
2027

Table 172: Indian Drugs of Abuse Testing Market Estimates and
Forecasts in US$ Million by Sample Type: 2020 to 2027

Table 173: Indian Drugs of Abuse Testing Historic Market Review
by Sample Type in US$ Million: 2012-2019

Table 174: Drugs of Abuse Testing Market in India: Percentage
Share Breakdown of Sales by Sample Type for 2012, 2020, and
2027

Table 175: Indian Drugs of Abuse Testing Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 176: Drugs of Abuse Testing Market in India:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 177: Indian Drugs of Abuse Testing Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 178: Drugs of Abuse Testing Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Product
Type for the Period 2020-2027

Table 179: South Korean Drugs of Abuse Testing Historic Market
Analysis in US$ Million by Product Type: 2012-2019

Table 180: Drugs of Abuse Testing Market Share Distribution in
South Korea by Product Type: 2012 VS 2020 VS 2027

Table 181: Drugs of Abuse Testing Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Sample Type
for the Period 2020-2027

Table 182: South Korean Drugs of Abuse Testing Historic Market
Analysis in US$ Million by Sample Type: 2012-2019

Table 183: Drugs of Abuse Testing Market Share Distribution in
South Korea by Sample Type: 2012 VS 2020 VS 2027

Table 184: Drugs of Abuse Testing Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by End-Use for
the Period 2020-2027

Table 185: South Korean Drugs of Abuse Testing Historic Market
Analysis in US$ Million by End-Use: 2012-2019

Table 186: Drugs of Abuse Testing Market Share Distribution in
South Korea by End-Use: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 187: Rest of Asia-Pacific Market for Drugs of Abuse
Testing: Annual Sales Estimates and Projections in US$ Million
by Product Type for the Period 2020-2027

Table 188: Drugs of Abuse Testing Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Product
Type for the Period 2012-2019

Table 189: Rest of Asia-Pacific Drugs of Abuse Testing Market
Share Analysis by Product Type: 2012 VS 2020 VS 2027

Table 190: Rest of Asia-Pacific Market for Drugs of Abuse
Testing: Annual Sales Estimates and Projections in US$ Million
by Sample Type for the Period 2020-2027

Table 191: Drugs of Abuse Testing Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Sample
Type for the Period 2012-2019

Table 192: Rest of Asia-Pacific Drugs of Abuse Testing Market
Share Analysis by Sample Type: 2012 VS 2020 VS 2027

Table 193: Rest of Asia-Pacific Demand Estimates and Forecasts
for Drugs of Abuse Testing in US$ Million by End-Use: 2020 to
2027

Table 194: Rest of Asia-Pacific Drugs of Abuse Testing Market
in US$ Million by End-Use: 2012-2019

Table 195: Drugs of Abuse Testing Market Share Shift in Rest of
Asia-Pacific by End-Use: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 196: Latin American Drugs of Abuse Testing Market Trends
by Region/Country in US$ Million: 2020-2027

Table 197: Drugs of Abuse Testing Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2012-2019

Table 198: Latin American Drugs of Abuse Testing Market
Percentage Breakdown of Sales by Region/Country: 2012, 2020,
and 2027

Table 199: Latin American Drugs of Abuse Testing Market Growth
Prospects in US$ Million by Product Type for the Period
2020-2027

Table 200: Drugs of Abuse Testing Historic Market Analysis in
Latin America in US$ Million by Product Type: 2012-2019

Table 201: Latin American Drugs of Abuse Testing Marketby
Product Type: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 202: Latin American Drugs of Abuse Testing Market Growth
Prospects in US$ Million by Sample Type for the Period
2020-2027

Table 203: Drugs of Abuse Testing Historic Market Analysis in
Latin America in US$ Million by Sample Type: 2012-2019

Table 204: Latin American Drugs of Abuse Testing Marketby
Sample Type: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 205: Latin American Demand for Drugs of Abuse Testing in
US$ Million by End-Use: 2020 to 2027

Table 206: Drugs of Abuse Testing Market Review in Latin
America in US$ Million by End-Use: 2012-2019

Table 207: Latin American Drugs of Abuse Testing Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027

ARGENTINA
Table 208: Argentinean Drugs of Abuse Testing Market Estimates
and Forecasts in US$ Million by Product Type: 2020-2027

Table 209: Drugs of Abuse Testing Market in Argentina in US$
Million by Product Type: A Historic Review for the Period
2012-2019

Table 210: Argentinean Drugs of Abuse Testing Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 211: Argentinean Drugs of Abuse Testing Market Estimates
and Forecasts in US$ Million by Sample Type: 2020-2027

Table 212: Drugs of Abuse Testing Market in Argentina in US$
Million by Sample Type: A Historic Review for the Period
2012-2019

Table 213: Argentinean Drugs of Abuse Testing Market Share
Breakdown by Sample Type: 2012 VS 2020 VS 2027

Table 214: Argentinean Drugs of Abuse Testing Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 215: Drugs of Abuse Testing Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 216: Argentinean Drugs of Abuse Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

BRAZIL
Table 217: Drugs of Abuse Testing Market in Brazil by Product
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 218: Brazilian Drugs of Abuse Testing Historic Market
Scenario in US$ Million by Product Type: 2012-2019

Table 219: Brazilian Drugs of Abuse Testing Market Share
Analysis by Product Type: 2012 VS 2020 VS 2027

Table 220: Drugs of Abuse Testing Market in Brazil by Sample
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 221: Brazilian Drugs of Abuse Testing Historic Market
Scenario in US$ Million by Sample Type: 2012-2019

Table 222: Brazilian Drugs of Abuse Testing Market Share
Analysis by Sample Type: 2012 VS 2020 VS 2027

Table 223: Drugs of Abuse Testing Quantitative Demand Analysis
in Brazil in US$ Million by End-Use: 2020-2027

Table 224: Brazilian Drugs of Abuse Testing Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 225: Brazilian Drugs of Abuse Testing Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

MEXICO
Table 226: Drugs of Abuse Testing Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Product
Type for the Period 2020-2027

Table 227: Mexican Drugs of Abuse Testing Historic Market
Analysis in US$ Million by Product Type: 2012-2019

Table 228: Mexican Drugs of Abuse Testing Market Share
Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 229: Drugs of Abuse Testing Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Sample Type
for the Period 2020-2027

Table 230: Mexican Drugs of Abuse Testing Historic Market
Analysis in US$ Million by Sample Type: 2012-2019

Table 231: Mexican Drugs of Abuse Testing Market Share
Breakdown by Sample Type: 2012 VS 2020 VS 2027

Table 232: Drugs of Abuse Testing Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 233: Mexican Drugs of Abuse Testing Market in Retrospect
in US$ Million by End-Use: 2012-2019

Table 234: Drugs of Abuse Testing Market Share Distribution in
Mexico by End-Use: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 235: Rest of Latin America Drugs of Abuse Testing Market
Estimates and Projections in US$ Million by Product Type: 2020
to 2027

Table 236: Drugs of Abuse Testing Market in Rest of Latin
America by Product Type: A Historic Review in US$ Million for
2012-2019

Table 237: Rest of Latin America Drugs of Abuse Testing Market
Share Breakdown by Product Type: 2012 VS 2020 VS 2027

Table 238: Rest of Latin America Drugs of Abuse Testing Market
Estimates and Projections in US$ Million by Sample Type: 2020
to 2027

Table 239: Drugs of Abuse Testing Market in Rest of Latin
America by Sample Type: A Historic Review in US$ Million for
2012-2019

Table 240: Rest of Latin America Drugs of Abuse Testing Market
Share Breakdown by Sample Type: 2012 VS 2020 VS 2027

Table 241: Rest of Latin America Drugs of Abuse Testing Latent
Demand Forecasts in US$ Million by End-Use: 2020 to 2027

Table 242: Drugs of Abuse Testing Historic Demand Patterns in
Rest of Latin America by End-Use in US$ Million for 2012-2019

Table 243: Drugs of Abuse Testing Market Share Breakdown in
Rest of Latin America by End-Use: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 244: The Middle East Drugs of Abuse Testing Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 245: Drugs of Abuse Testing Market in the Middle East by
Region/Country in US$ Million: 2012-2019

Table 246: The Middle East Drugs of Abuse Testing Market Share
Breakdown by Region/Country: 2012, 2020, and 2027

Table 247: The Middle East Drugs of Abuse Testing Market
Estimates and Forecasts in US$ Million by Product Type: 2020 to
2027

Table 248: The Middle East Drugs of Abuse Testing Historic
Marketby Product Type in US$ Million: 2012-2019

Table 249: Drugs of Abuse Testing Market in the Middle East:
Percentage Share Breakdown of Salesby Product Type for
2012,2020, and 2027

Table 250: The Middle East Drugs of Abuse Testing Market
Estimates and Forecasts in US$ Million by Sample Type: 2020 to
2027

Table 251: The Middle East Drugs of Abuse Testing Historic
Marketby Sample Type in US$ Million: 2012-2019

Table 252: Drugs of Abuse Testing Market in the Middle East:
Percentage Share Breakdown of Salesby Sample Type for
2012,2020, and 2027

Table 253: The Middle East Drugs of Abuse Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 254: Drugs of Abuse Testing Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 255: The Middle East Drugs of Abuse Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

IRAN
Table 256: Iranian Market for Drugs of Abuse Testing: Annual
Sales Estimates and Projections in US$ Million by Product Type
for the Period 2020-2027

Table 257: Drugs of Abuse Testing Market in Iran: Historic
Sales Analysis in US$ Million by Product Type for the Period
2012-2019

Table 258: Iranian Drugs of Abuse Testing Market Share Analysis
by Product Type: 2012 VS 2020 VS 2027

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05960901/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001